Gainers
- Surgalign Holdings SRGA shares rose 3.1% to $0.32 during Friday's after-market session. Today's trading volume for this security ended up closing at 72.6K shares, which is 2.1 percent of its average volume over the last 100 days. The company's market cap stands at $62.8 million.
- MannKind MNKD shares moved upwards by 2.2% to $2.78. The company's market cap stands at $698.4 million. As per the press release, Q4 earnings came out yesterday.
- Plus Therapeutics PSTV shares moved upwards by 1.94% to $1.05. The company's market cap stands at $22.2 million. As per the press release, Q4 earnings came out yesterday.
- Alzamend Neuro ALZN shares increased by 1.73% to $1.17. The market value of their outstanding shares is at $103.9 million.
- Jaguar Health JAGX stock increased by 1.64% to $0.47. The market value of their outstanding shares is at $24.0 million.
- Verastem VSTM shares rose 1.62% to $1.25. The market value of their outstanding shares is at $227.7 million.
Losers
- Agile Therapeutics AGRX shares declined by 5.7% to $0.29 during Friday's after-market session. The market value of their outstanding shares is at $35.2 million.
- Checkpoint Therapeutics CKPT shares decreased by 4.45% to $1.72. The company's market cap stands at $144.0 million.
- Butterfly Network BFLY stock declined by 4.38% to $5.46. This security traded at a volume of 71.3K shares come close, making up 2.3% of its average volume over the last 100 days. The market value of their outstanding shares is at $1.0 billion.
- Myovant Sciences MYOV shares fell 3.63% to $13.02. The market value of their outstanding shares is at $1.2 billion.
- Clovis Oncology CLVS shares decreased by 2.95% to $1.98. At the close, Clovis Oncology's trading volume reached 76.8K shares. This is 1.8% of its average volume over the last 100 days. The market value of their outstanding shares is at $257.3 million. As per the press release, Q4 earnings came out 2 days ago.
- GBS GBS shares declined by 2.88% to $0.49. The market value of their outstanding shares is at $7.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in